PAYSON, Ariz. –
Ally Biotech, a science-based company and provider of leading-edge bioactive delivery solutions for cannabinoids, today announced the acquisition of the popular Chill Pill brand, an expansive line of soft, easy-to-swallow soft gel caps and all of its assets, from Desert Medical Campus, an all cash transaction.
The Chills Pill, founded in 2018 by Andrew Provencio at his Desert Medical Campus, was the first THC soft gel cap on the market in Arizona and quickly gained domination within its product category for both medical and adult use consumers, which it still maintains. The expansive line is distributed in nearly 50 licensed Arizona dispensaries.
Ally Biotech is a cannabis science company behind the Lipofusion delivery technology, considered the next generation of oral delivery technologies for the cannabinoid market. Their proprietary nanoliposomal technology protects bioactives from degradation in the digestive system and provides effective and increased absorption on the cellular level.
Company president, Jim Mackowiak, said plans are underway to expand the Chill Pill line to include new products that are developed with highly bioavailable custom formulations. “The new wave of cannabis consumers value rapid-onset products that are consistent and safe,” he said. The company’s VP of business development, Francis Baczek agrees, “The Chill Pill provides a great delivery system for a consistently accurate dose. We are excited to add new products, expand our team, and to bring science and technology to the expansion of business and the brand”
“We have seen tremendous success with the Chill Pill because consumers rely upon the brand’s accurate dosing, convenience, consistency and predictable therapeutic effects. Ally Biotech will continue building upon our strong vision for both the medical and adult use markets, and is well poised to successfully expand the brand,” he said. Provencio’s long-time business partner, Pam Donner, agrees. “The company is in good hands with the innovative team at Ally Biotech,” she said.
Mackowiak added that the company has hired key Desert Medical employees and will build a culture of excellence while supporting economic development in Payson, where the current facility is located.
The Chill Pill soft gel cap line includes:
Day Caps – a sativa dominant formula.
Anytime Caps – a formulation that combines sativa and indica.
Night Caps – an indica dominant formula.
Anytime Caps + CBD – a 1:1 blend of THC and CBD.
THC-A – Non-intoxicating symptom relief with no psychoactive effects.
For more information on Ally Biotech,visit AllyBiotech.com. For more information about the Chill Pill, visit ChillPillsAZ.com
###
About Ally Biotech:
Headquartered in Payson, Arizona, Ally Biotech offers highly bioavailable products to leading manufacturers and dispensaries of cannabis products. The Company’s Lipofusion delivery technology combines nanotechnology and liposomal science to speed product differentiation and innovation. Ally Biotech offers product development services, and manufacturing-ready, water soluble Lipofusion THC that can be utilized as a raw ingredient in powder or liquid form in a variety of products. All of the company’s products undergo rigorous testing for purity, potency, safety and efficacy at third-party laboratories. For more information, visit AllyBiotech.com.
About Desert Medical Campus, Inc, originator of the Chill Pill:
Desert Medical Campus, Inc., is a vertically integrated company involved with virtually all aspects of the cannabis and hemp industries, including cultivation, processing, manufacturing, product and brand development, and dispensary operations. The company owns or has been integrally involved with the development of some of the leading, and most award-winning brands in the nation. Desert Medical Campus, Inc is headquartered in Payson, Arizona, and serves clients nationwide. Andrew Provencio, founder of the organization, developed the Chills Pills soft gel cap line in 2018. For more information, visit ChillPillsAZ.com.
